Format

Send to

Choose Destination
Oncotarget. 2017 Dec 6;9(2):1931-1943. doi: 10.18632/oncotarget.23026. eCollection 2018 Jan 5.

MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

Fu F#1, Wan X#1, Wang D1, Kong Z1, Zhang Y1, Huang W1, Wang C1,2, Wu H1,2, Li Y1,2.

Author information

1
Obstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai 200433, PR China.
2
Key Laboratory of Reproduction Regulation of NPFPC, Fudan University, Shanghai 200433, PR China.
#
Contributed equally

Abstract

Prostate cancer (PCa) is a leading cause of cancer-related deaths among males worldwide. However, the molecular mechanisms underlying the progression of PCa remain unclear. Despite several reported miRNAs in prostate cancer, these reports lacked system-level identification of differentially expressed miRNAs in large sample size. Moreover, it's still largely unknown how miRNAs result in tumorigenesis and progression of PCa. Therefore, by analyzing three public databases, we identified 16 upregulated miRNAs and 13 downregulated miRNAs, and validated miR-19a was one of the most upregulated miRNAs using qRT-PCR. The dual-luciferase reporter assays indicated VPS37A was a potential target of miR-19a. Functional assays revealed miR-19a served as an oncogene by inhibiting VPS37A. Notably, a significant inverse correlation of miR-19a and VPS37A expression was observed in PCa specimens. Moreover, miR-19a-high and VPS37A-low phenotypes were associated with poor prognosis with biochemical recurrence-free probability. In this study, we confirmed the oncogenic role of miR-19a via targeting VPS37A in PCa, identifying miR-19a and VPS37A as diagnosis and therapeutic biomarkers for PCa.

KEYWORDS:

VPS37A; microRNA-19a; prognostic marker; prostate cancer; tumor progression

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare that they have no competing interests.

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center